Apparent diffusion coefficients of breast tumors: clinical application.

scientific article published in January 2008

Apparent diffusion coefficients of breast tumors: clinical application. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2463/MRMS.7.23
P698PubMed publication ID18460845

P50authorMasamitsu HatakenakaQ45396143
H HondaQ88632968
P2093author name stringYoshio Matsuo
Yoshinao Oda
Masazumi Tsuneyoshi
Hidetake Yabuuchi
Hiroyasu Soeda
Takeshi Kamitani
P433issue1
P304page(s)23-29
P577publication date2008-01-01
P1433published inMagnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in MedicineQ26842414
P1476titleApparent diffusion coefficients of breast tumors: clinical application.
P478volume7

Reverse relations

cites work (P2860)
Q41292151A pilot evaluation of magnetic resonance imaging characteristics seen with solid papillary carcinomas of the breast in 4 patients
Q53187901A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result?
Q53121836An intraoperative MRI system for margin assessment in breast conserving surgery: Initial results from a novel technique.
Q37328026Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer
Q53076800Apparent diffusion coefficient as a potential surrogate marker for Ki-67 index in mucinous breast carcinoma.
Q51546104Apparent diffusion coefficient calculated with relatively high b-values correlates with local failure of head and neck squamous cell carcinoma treated with radiotherapy.
Q30730091Apparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy
Q38018542Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review
Q36839178Apparent diffusion coefficient value in invasive ductal carcinoma at 3.0 Tesla: is it correlated with prognostic factors?
Q35614931Assessment of tumor morphology on diffusion-weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI
Q48115092Associations among q-space MRI, diffusion-weighted MRI and histopathological parameters in meningiomas
Q33965703Breast MR with special focus on DW-MRI and DCE-MRI
Q38234778Clinical evaluation and management of benign soft tissue tumors of the extremities
Q34757933Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation
Q34097311Comparisons of multi b-value DWI signal analysis with pathological specimen of breast cancer
Q34361556Conspicuity of breast lesions at different b values on diffusion-weighted imaging
Q41709190Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis
Q87984148Correlation between electrical conductivity and apparent diffusion coefficient in breast cancer: effect of necrosis on magnetic resonance imaging
Q33760804Correlation of Prognostic Factors of Invasive Lobular Carcinoma with ADC Value of DWI and SUVMax of FDG-PET
Q44247897Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients
Q36653229Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer
Q46796620Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla
Q37538876Diagnosis of breast masses from dynamic contrast-enhanced and diffusion-weighted MR: a machine learning approach.
Q42122502Diagnostic Value of Diffusion-weighted Imaging and Apparent Diffusion Coefficient Values in the Differentiation of Breast Lesions, Histpathologic Subgroups and Correlatıon with Prognostıc Factors using 3.0 Tesla MR
Q33677899Diagnostic assessment by dynamic contrast-enhanced and diffusion-weighted magnetic resonance in differentiation of breast lesions under different imaging protocols
Q38219736Diagnostic efficacy of the diffusion weighted imaging in the characterization of different types of breast lesions.
Q94570799Diagnostic performance of breast tumor tissue selection in diffusion weighted imaging: A systematic review and meta-analysis
Q33857530Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study
Q35083961Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging
Q53829468Diffusion Tensor Imaging for Assessment of Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Q42139166Diffusion tensor imaging of breast lesions: evaluation of apparent diffusion coefficient and fractional anisotropy and tissue cellularity
Q84612704Diffusion tensor magnetic resonance imaging of the breast: a pilot study
Q38009677Diffusion tensor magnetic resonance imaging of the normal breast: reproducibility of DTI-derived fractional anisotropy and apparent diffusion coefficient at 3.0 T.
Q53561619Diffusion weighted imaging and apparent diffusion coefficient in 3 tesla magnetic resonance imaging of breast lesions.
Q37087591Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications.
Q51833677Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions.
Q83479168Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques
Q52986909Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
Q36237072Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma
Q50308589Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A meta-analysis
Q51830723Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values.
Q33823280Diffusion-weighted imaging: determination of the best pair of b-values to discriminate breast lesions
Q44736400Diffusion-weighted magnetic resonance imaging combined with T2-weighted images in the detection of small breast cancer: a single-center multi-observer study
Q82454963Diffusion-weighted magnetic resonance imaging in focal breast lesions: analysis of 78 cases with pathological correlation
Q88017670Diffusion-weighted magnetic resonance imaging of breast lesions: the influence of different fat-suppression techniques on quantitative measurements and their reproducibility
Q55624869Discrimination of malignant and benign breast masses using automatic segmentation and features extracted from dynamic contrast-enhanced and diffusion-weighted MRI.
Q34951384Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy
Q30896010Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis
Q42979883FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion
Q53027160Fat suppression techniques (STIR vs. SPAIR) on diffusion-weighted imaging of breast lesions at 3.0 T: preliminary experience.
Q30474460Functional magnetic resonance: biomarkers of response in breast cancer
Q41005538Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
Q35447075Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics.
Q38960247Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer
Q35093223Investigation of the optimal b-value to detect breast tumors with diffusion weighted imaging by 1.5-T MRI.
Q47817346Is the necrosis/wall ADC ratio useful for the differentiation of benign and malignant breast lesions?
Q89847109MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses
Q38202564MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies
Q53062797Magnetic resonance imaging features of idiopathic granulomatous mastitis: is there any contribution of diffusion-weighted imaging in the differential diagnosis?
Q33873362Magnetic resonance in the detection of breast cancers of different histological types
Q85259257Mediastinal paraganglioma
Q33781446Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions
Q37593722Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study.
Q37776141Molecular and Functional Imaging of Breast Cancer
Q34380422Molecular imaging of water binding state and diffusion in breast cancer using diffuse optical spectroscopy and diffusion weighted MRI
Q57181772Non-Invasive Quantification of Cell Density in 3D Gels by MRI
Q63990402Noninvasive Quantification of Cell Density in Three-Dimensional Gels by MRI
Q36417710Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging
Q54176725Optimization of apparent diffusion coefficient measured by diffusion-weighted MRI for diagnosis of breast lesions presenting as mass and non-mass-like enhancement.
Q36925030Potential of Diffusion-Weighted Imaging in the Characterization of Malignant, Benign, and Healthy Breast Tissues and Molecular Subtypes of Breast Cancer.
Q35860283Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: a retrospective study of 541 cases
Q43114082Qualitative and quantitative diffusion-weighted imaging of the breast at 3T - A useful adjunct to contrast-enhanced MRI in characterization of breast lesions
Q36689284Quantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations
Q34155874Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity
Q53088793Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Q36317605Role of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient values in the detection of gastric carcinoma
Q84948712Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions
Q49499170Stromal fibrosis: imaging features with diagnostic contribution of diffusion weighted MR imaging.
Q57742687The contribution of diffusion tensor imaging and magnetic resonance spectroscopy for the differentiation of breast lesions at 3T
Q37297789The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis
Q50984483The diagnostic value of diffusion-weighted imaging and the apparent diffusion coefficient values in the differentiation of benign and malignant breast lesions.
Q43275527The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study.
Q33814091The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results.
Q58604567Two Different Methods of Region-of-Interest Placement for Differentiation of Benign and Malignant Breast Lesions by Apparent Diffusion Coefficient Value
Q84590317Usefulness of diffusion-weighted imaging of breast tumors: quantitative and visual assessment
Q36983703Value of Apparent Diffusion Coefficient Values in Differentiating Malignant and Benign Breast Lesions
Q84951684Value of diffusion-weighted MRI in the differentiation of benign and malign breast lesions
Q53292844[Diffusion-weighted MR imaging of the breast]
Q53077782[Diffusion-weighted breast imaging. Clinical implementation procedure].

Search more.